Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Aviv, AVX, Baracca, Box, creation, Cure, decrease, Delaware, DNase, Easy, error, Escape, expansion, founder, fundraising, gap, Georgy, GT, Himalaya, Home, inception, INMD, InMode, intent, interventional, Israel, Italy, Kingdom, Kyocera, liability, Maguire, MBA, Mezzeine, Milan, mitigation, Mizrahy, Moshe, Nitzanim, NY, oard, oncology, Pace, partial, Pazzale, Pet, platform, PO, Polimer, recovery, reduced, Rescue, Schedule, Scott, SipNose, Sublicense, subscribe, Syneron, Tel, ultimate, unmet, Urifer, Varick, Victor, VT, York
Filing tables
Filing exhibits
XBIO similar filings
Filing view
External links
EXHIBIT 31.3
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Jeffrey F. Eisenberg, certify that:
1. | I have reviewed this Amendment No. 1 to the annual report on Form 10-K of Xenetic Biosciences, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Dated: April 26, 2024
By: | /s/ Jeffrey F. Eisenberg |
Jeffrey F. Eisenberg | |
Chief Executive Officer | |
(Principal Executive Officer) |